Amedeo Smart

Free Medical Literature Service

 

Amedeo

Bacterial Infections and Mycoses
  Free Subscription

Articles published in
J Antimicrob Chemother
    June 2023
  1. QIAN C, Ma Z, Feng L, Guo W, et al
    Emergence of tet(X2) in Acinetobacter pittii confers clinical resistance to tigecycline.
    J Antimicrob Chemother. 2023;78:1543-1546.
    >> Share

  2. GATTI M, Pea F
    Comment on: pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections.
    J Antimicrob Chemother. 2023;78:1556-1557.
    >> Share

  3. WORTMAN JM, Leegwater E, Van Lammeren-Venema D, Van Nieuwkoop C, et al
    Drug-drug interaction: decreased posaconazole trough concentrations during concomitant flucloxacillin treatment.
    J Antimicrob Chemother. 2023;78:1471-1475.
    >> Share

    May 2023
  4. CINTHI M, Massacci FR, Coccitto SN, Albini E, et al
    Characterization of a prophage and a defective integrative conjugative element carrying the optrA gene in linezolid-resistant Streptococcus dysgalactiae subsp. equisimilis isolates from pigs, Italy.
    J Antimicrob Chemother. 2023 May 31:dkad164. doi: 10.1093.
    >> Share

  5. COCCITTO SN, Massacci FR, Cinthi M, Albini E, et al
    Co-location of the oxazolidinone resistance poxtA2 and cfr(D) genes on a multiresistance plasmid from a porcine Streptococcus dysgalactiae subsp. equisimilis, Italy.
    J Antimicrob Chemother. 2023 May 30:dkad169. doi: 10.1093.
    >> Share

  6. LALANNE S, Cattoir V, Guerin F, Verdier MC, et al
    Differential response to antibiotic therapy in staphylococcal infective endocarditis: contribution of an ex vivo model.
    J Antimicrob Chemother. 2023 May 30:dkad155. doi: 10.1093.
    >> Share


  7. Correction to: Comparative effectiveness of beta-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study.
    J Antimicrob Chemother. 2023 May 23:dkad153. doi: 10.1093.
    >> Share

  8. SHEN W, Zhang R, Cai J
    Co-occurrence of multiple plasmid-borne linezolid resistance genes-optrA, cfr, poxtA2 and cfr(D) in an Enterococcus faecalis isolate from retail meat.
    J Antimicrob Chemother. 2023 May 20:dkad142. doi: 10.1093.
    >> Share

  9. SCHELLENBERG JJ, Adam HJ, Baxter MR, Karlowsky JA, et al
    Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine coverage of invasive Streptococcus pneumoniae isolate serotypes in Canada: the SAVE study, 2011-20.
    J Antimicrob Chemother. 2023;78.
    >> Share

  10. GOLDEN AR, Adam HJ, Karlowsky JA, Baxter M, et al
    Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-2020.
    J Antimicrob Chemother. 2023;78.
    >> Share

  11. ADAM HJ, Karlowsky JA, Baxter MR, Schellenberg J, et al
    Analysis of MDR in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-2020.
    J Antimicrob Chemother. 2023;78.
    >> Share

  12. ZHANEL GG, Lynch JP, Adam HJ
    Streptococcus pneumoniae serotyping and antimicrobial susceptibility: assessment for vaccine efficacy in Canada after the introduction of PCV13.
    J Antimicrob Chemother. 2023;78.
    >> Share

  13. ALFORD MA, Karlowsky JA, Adam HJ, Baxter MR, et al
    Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-2020.
    J Antimicrob Chemother. 2023;78.
    >> Share

  14. ELIAS R, Spadar A, Hendrickx APA, Bonnin RA, et al
    Emergence of KPC-3- and OXA-181-producing ST13 and ST17 Klebsiella pneumoniae in Portugal: genomic insights on national and international dissemination.
    J Antimicrob Chemother. 2023;78:1300-1308.
    >> Share

  15. SIMJEE S, Gould G, Maduro L, Boulianne M, et al
    No change in avilamycin (Surmax(R) Premix) minimum inhibitory concentration for Clostridium perfringens isolates recovered from poultry up to 7 years post-approval in Canada.
    J Antimicrob Chemother. 2023;78:1278-1281.
    >> Share

  16. GONZALEZ C, Volland H, Oueslati S, Niol L, et al
    Evaluation of a new rapid immunochromatographic assay for the detection of GES-producing Gram-negative bacteria.
    J Antimicrob Chemother. 2023;78:1282-1287.
    >> Share

  17. CASTILLO-POLO JA, Hernandez-Garcia M, Morosini MI, Perez-Viso B, et al
    Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain.
    J Antimicrob Chemother. 2023;78:1259-1264.
    >> Share

  18. ALONSO-GARCIA I, Vazquez-Ucha JC, Lasarte-Monterrubio C, Gonzalez-Mayo E, et al
    Simultaneous and divergent evolution of resistance to cephalosporin/beta-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections.
    J Antimicrob Chemother. 2023;78:1195-1200.
    >> Share

  19. JIA M, Zhou W, Luo D, Xue H, et al
    Calcium-binding motif-mediated binding of redundant calcium offers a chimeolysin enhanced bactericidal activity and extended host range under physiological conditions.
    J Antimicrob Chemother. 2023;78:1182-1190.
    >> Share

    April 2023
  20. DASHTBANI-ROOZBEHANI A, Chitsaz M, Brown MH
    The role of TMS 12 in the staphylococcal multidrug efflux protein QacA.
    J Antimicrob Chemother. 2023 Apr 26:dkad121. doi: 10.1093.
    >> Share

  21. DANESHNIA F, Hilmioglu-Polat S, Ilkit M, Fuentes D, et al
    Whole-genome sequencing confirms a persistent candidaemia clonal outbreak due to multidrug-resistant Candida parapsilosis.
    J Antimicrob Chemother. 2023 Apr 26:dkad112. doi: 10.1093.
    >> Share

  22. HENDERSON A, Cheng MP, Chew KL, Coombs GW, et al
    A multi-site, international laboratory study to assess the performance of penicillin susceptibility testing of Staphylococcus aureus.
    J Antimicrob Chemother. 2023 Apr 18:dkad116. doi: 10.1093.
    >> Share

  23. BEREDAKI MI, Arendrup MC, Andes D, Meletiadis J, et al
    Development of an in vitro pharmacokinetic/pharmacodynamic model in the presence of serum for studying micafungin activity against Candida albicans: a need for revision of CLSI susceptibility breakpoints.
    J Antimicrob Chemother. 2023 Apr 18:dkad096. doi: 10.1093.
    >> Share

  24. LAFAURIE M, Montlahuc C, Kerneis S, de Lastours V, et al
    Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer.
    J Antimicrob Chemother. 2023 Apr 4:dkad083. doi: 10.1093.
    >> Share

  25. SALEHI M, Farbod F, Khalili H, Rahmani H, et al
    Comparing efficacy and safety of high-dose and standard-dose rifampicin in the treatment of brucellosis: a randomized clinical trial.
    J Antimicrob Chemother. 2023;78:1084-1091.
    >> Share

  26. LU B, Wong M, Ha D, Bounthavong M, et al
    Piperacillin/tazobactam versus cefepime or carbapenems for cefoxitin-non-susceptible Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii, Serratia marcescens and Morganella morganii bacteraemia in immunocompromised patients.
    J Antimicrob Chemother. 2023;78:1009-1014.
    >> Share

  27. KUFEL WD, Hitchcock AM, Delbalso AN, Paolino KM, et al
    Evaluation of fidaxomicin use in patients with a macrolide allergy/intolerance.
    J Antimicrob Chemother. 2023;78:1127-1128.
    >> Share

  28. SPERNOVASILIS N, Kritsotakis EI, Mathioudaki A, Vouidaski A, et al
    A carbapenem-focused antimicrobial stewardship programme implemented during the COVID-19 pandemic in a setting of high endemicity for multidrug-resistant Gram-negative bacteria.
    J Antimicrob Chemother. 2023;78:1000-1008.
    >> Share

    March 2023
  29. DIERIKX C, Hengeveld P, Witteveen S, van Hoek A, et al
    Genomic comparison of mecC-carrying methicillin-resistant Staphylococcus aureus from hedgehogs and humans in the Netherlands.
    J Antimicrob Chemother. 2023 Mar 30:dkad047. doi: 10.1093.
    >> Share

  30. CAREY GB, Holleck JL, Ein Alshaeba S, Jayakrishnan R, et al
    Estimated mortality with early empirical antibiotic coverage of methicillin-resistant Staphylococcus aureus in hospitalized patients with bacterial infections: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2023 Mar 25:dkad078. doi: 10.1093.
    >> Share

  31. KIME L, Waring T, Mohamad M, Mann BF, et al
    Resistance to antibacterial antifolates in multidrug-resistant Staphylococcus aureus: prevalence estimates and genetic basis.
    J Antimicrob Chemother. 2023 Mar 20:dkad063. doi: 10.1093.
    >> Share

  32. YAMAGUCHI R, Yamamoto T, Okamoto K, Harada S, et al
    Teicoplanin and vancomycin as treatment for glycopeptide-susceptible Enterococcus faecium bacteraemia: a propensity score-adjusted non-inferior comparative study.
    J Antimicrob Chemother. 2023 Mar 15:dkad079. doi: 10.1093.
    >> Share

  33. BUIS DTP, van der Vaart TW, Prins JM, van der Meer JTM, et al
    Comparative effectiveness of beta-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study.
    J Antimicrob Chemother. 2023 Mar 10:dkad057. doi: 10.1093.
    >> Share

  34. WATKINS RR, Thapaliya D, Lemonovich TL, Bonomo RA, et al
    Gepotidacin: a novel, oral, 'first-in-class' triazaacenaphthylene antibiotic for the treatment of uncomplicated urinary tract infections and urogenital gonorrhoea.
    J Antimicrob Chemother. 2023 Mar 8:dkad060. doi: 10.1093.
    >> Share

  35. SPADARI CC, Lanser DM, Araujo MV, De Jesus DFF, et al
    Oral delivery of brain-targeted miltefosine-loaded alginate nanoparticles functionalized with polysorbate 80 for the treatment of cryptococcal meningitis.
    J Antimicrob Chemother. 2023 Mar 7:dkad053. doi: 10.1093.
    >> Share

  36. HEIL EL, Claeys KC, Kline EG, Rogers TM, et al
    Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients.
    J Antimicrob Chemother. 2023 Mar 3:dkad042. doi: 10.1093.
    >> Share

  37. ESCUDERO-SANCHEZ R, Rubio Martin E, Vizcarra P, Braojos Sanchez F, et al
    Conventional versus extended-pulsed fidaxomicin dosing in patients at high risk of recurrence of Clostridioides difficile infection: a propensity score analysis.
    J Antimicrob Chemother. 2023;78:823-827.
    >> Share

  38. MCCURDY S, Halasohoris SA, Babyak AL, Lembirik S, et al
    Efficacy of delafloxacin against the biothreat pathogen Bacillus anthracis.
    J Antimicrob Chemother. 2023;78:810-816.
    >> Share

  39. DING ZH, Huang Y, Chen JN, Luo LS, et al
    A randomized superiority clinical trial: metronidazole improved the efficacy of high-dose dual therapy in Helicobacter pylori rescue treatment.
    J Antimicrob Chemother. 2023;78:828-831.
    >> Share

  40. FRESAN D, Luque S, Benitez-Cano A, Sorli L, et al
    Pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections.
    J Antimicrob Chemother. 2023;78:678-683.
    >> Share

  41. NUNN R, Clifford C, Merali Z
    Successful treatment of recurrent Clostridioides difficile infection by administration of crushed fidaxomicin via gastro-jejunal tube.
    J Antimicrob Chemother. 2023;78:850-851.
    >> Share

    February 2023
  42. GUO Y, Han R, Zhang G, Yang Q, et al
    Setting of the tentative epidemiological cut-off values of contezolid for Staphylococcus aureus, Enterococcus faecalis, Enterococcus faecium, Streptococcus pneumoniae and Streptococcus agalactiae.
    J Antimicrob Chemother. 2023 Feb 28:dkad045. doi: 10.1093.
    >> Share

  43. KANEKO H, Yanagi Y, Otake S, Sato M, et al
    The emerging threat of methicillin-resistant Staphylococcus aureus (MRSA) clone ST22-PT, carrying both Panton-Valentine leucocidin and toxic shock syndrome toxin 1 genes.
    J Antimicrob Chemother. 2023 Feb 23:dkad039. doi: 10.1093.
    >> Share

  44. GUMBO T, Srivastava S, Deshpande D, Pasipanodya JG, et al
    Hollow-fibre system model of tuberculosis reproducibility and performance specifications for best practice in drug and combination therapy development.
    J Antimicrob Chemother. 2023 Feb 16:dkad029. doi: 10.1093.
    >> Share

  45. BELLOUARD R, Rambaud A, Delaunay C, Dailly E, et al
    Development and validation of a dosing nomogram for continuous infusion cloxacillin in infective endocarditis.
    J Antimicrob Chemother. 2023 Feb 10:dkad030. doi: 10.1093.
    >> Share

  46. MORENO-MINGORANCE A, Mir-Cros A, Goterris L, Rodriguez-Garrido V, et al
    Increasing trend of antimicrobial resistance in Shigella associated with MSM transmission in Barcelona, 2020-21: outbreak of XRD Shigella sonnei and dissemination of ESBL-producing Shigella flexneri.
    J Antimicrob Chemother. 2023 Feb 10:dkad031. doi: 10.1093.
    >> Share

  47. CHEN H, Tao S, Li N, Zhu Q, et al
    Anti-restriction protein ArdA promotes clinical Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae spread and its molecular mechanism.
    J Antimicrob Chemother. 2023;78:521-530.
    >> Share

  48. BAE S, Kim ES, Lee YW, Jung J, et al
    Clinical and microbiological characteristics of rifampicin-resistant MRSA bacteraemia.
    J Antimicrob Chemother. 2023;78:531-539.
    >> Share

  49. YOUENOU B, Martins Simoes P, Tristan A, Farfour E, et al
    Linezolid resistance: detection of the cfr(B) gene in French clinical MRSA strains.
    J Antimicrob Chemother. 2023;78:445-449.
    >> Share

  50. LI Y, Liu Q, She J, Qiu Y, et al
    IS26-mediated in vivo acquisition of blaKPC-2 in an ST11-K64 Klebsiella pneumoniae isolate from a senile inpatient.
    J Antimicrob Chemother. 2023;78:550-553.
    >> Share

  51. VALLEE M, Harding C, Hall J, Aldridge PD, et al
    Exploring the in situ evolution of nitrofurantoin resistance in clinically derived uropathogenic Escherichia coli isolates.
    J Antimicrob Chemother. 2023;78:373-379.
    >> Share

    January 2023
  52. HU J, Chen L, Li G, Pan Y, et al
    Prevalence and genetic characteristics of fosB-positive Staphylococcus aureus in duck farms in Guangdong, China in 2020.
    J Antimicrob Chemother. 2023 Jan 24:dkad014. doi: 10.1093.
    >> Share

  53. ROBSON C, Tan B, Stuart R, Nicholls S, et al
    A systematic review of optimal pharmacokinetic/pharmacodynamic parameters for beta-lactam therapy in infective endocarditis.
    J Antimicrob Chemother. 2023 Jan 24:dkad005. doi: 10.1093.
    >> Share

  54. CHEN L, Hua J, Hong SJ, Yuan CY, et al
    Comparison of the relative efficacy of beta-lactam/beta-lactamase inhibitors and carbapenems in the treatment of complicated urinary tract infections caused by ceftriaxone-non-susceptible Enterobacterales: a multicentre retrospective observational coh
    J Antimicrob Chemother. 2023 Jan 24:dkac448. doi: 10.1093.
    >> Share

  55. LI XX, Zhang FQ, Wang S, Duan XC, et al
    Streptococcus suis prophage lysin as a new strategy for combating streptococci-induced mastitis and Streptococcus suis infection.
    J Antimicrob Chemother. 2023 Jan 20:dkad006. doi: 10.1093.
    >> Share

  56. AL JANABI J, Tevell S, Sieber RN, Stegger M, et al
    Emerging resistance in Staphylococcus epidermidis during dalbavancin exposure: a case report and in vitro analysis of isolates from prosthetic joint infections.
    J Antimicrob Chemother. 2023 Jan 6:dkac434. doi: 10.1093.
    >> Share

    December 2022
  57. POUGET C, Pantel A, Dunyach-Remy C, Magnan C, et al
    Antimicrobial activity of antibiotics on biofilm formed by Staphylococcus aureus and Pseudomonas aeruginosa in an open microfluidic model mimicking the diabetic foot environment.
    J Antimicrob Chemother. 2022 Dec 28:dkac438. doi: 10.1093.
    >> Share

  58. ZENG W, Han Y, Zheng X, Yao Z, et al
    Evaluation of resazurin microplate method for rapid detection of vancomycin and linezolid resistance in Enterococcus faecalis and Enterococcus faecium clinical isolates.
    J Antimicrob Chemother. 2022 Dec 28:dkac415. doi: 10.1093.
    >> Share

  59. BISHOP EJ, Tiruvoipati R
    Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines.
    J Antimicrob Chemother. 2022;78:21-30.
    >> Share

  60. FRIMODT-MOLLER N, Simonsen GS, Larsen AR, Kahlmeter G, et al
    Pivmecillinam, the paradigm of an antibiotic with low resistance rates in Escherichia coli urine isolates despite high consumption.
    J Antimicrob Chemother. 2022;78:289-295.
    >> Share

  61. MAUCK CK, Atiee GJ, McCulloh J, Reynolds L, et al
    A Phase 1 pharmacokinetic study of a single-dose bioadhesive clindamycin 2% gel for bacterial vaginosis.
    J Antimicrob Chemother. 2022;78:257-262.
    >> Share

  62. WU K, Wang J, Feng H, Li R, et al
    Complete genome sequence and characterization of Clostridium perfringens type D carrying optrA-plasmid and Tn6218-like transposon.
    J Antimicrob Chemother. 2022;78:311-313.
    >> Share

  63. ZHAO B, Han H, He K, Hou WF, et al
    Decreased cyclic-AMP caused by ATP contributes to fosfomycin heteroresistance in avian Escherichia coli.
    J Antimicrob Chemother. 2022;78:216-224.
    >> Share

  64. ABD ALGAFFAR SO, Verbon A, Khalid SA, van de Sande WWJ, et al
    Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma.
    J Antimicrob Chemother. 2022;78:155-160.
    >> Share

  65. GOLPARIAN D, Jacobsson S, Sanchez-Buso L, Bazzo ML, et al
    GyrB in silico mining in 27 151 global gonococcal genomes from 1928-2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and ParE substitutions confirms high susceptibility.
    J Antimicrob Chemother. 2022;78:150-154.
    >> Share

  66. MANTZOURANI E, Wasag D, Cannings-John R, Ahmed H, et al
    Characteristics of the sore throat test and treat service in community pharmacies (STREP) in Wales: cross-sectional analysis of 11 304 consultations using anonymized electronic pharmacy records.
    J Antimicrob Chemother. 2022;78:84-92.
    >> Share

  67. ANTONELLO RM, Canetti D, Riccardi N
    Daptomycin synergistic properties from in vitro and in vivo studies: a systematic review.
    J Antimicrob Chemother. 2022;78:52-77.
    >> Share

  68. WAN TW, Yeo HH, Lee TF, Huang YT, et al
    Molecular epidemiology of bacteraemic vancomycin-resistant Enterococcus faecium isolates and in vitro activities of SC5005 and other comparators against these isolates collected from a medical centre in northern Taiwan, 2019-2020.
    J Antimicrob Chemother. 2022 Dec 17:dkac414. doi: 10.1093.
    >> Share

  69. XUAN H, Xia L, Schwarz S, Jia H, et al
    Various mobile genetic elements carrying optrA in Enterococcus faecium and Enterococcus faecalis isolates from swine within the same farm.
    J Antimicrob Chemother. 2022 Dec 12:dkac421. doi: 10.1093.
    >> Share

  70. XIAO J, Huang J, Xue X, Wang C, et al
    Novel cassette chromosome recombinases CcrA8B9 catalyse the excision and integration of the staphylococcal cassette chromosome mec element.
    J Antimicrob Chemother. 2022 Dec 8:dkac410. doi: 10.1093.
    >> Share

    November 2022
  71. LE MOIGNE V, Blouquit-Laye S, Desquesnes A, Girard-Misguich F, et al
    Liposomal amikacin and Mycobacterium abscessus: intimate interactions inside eukaryotic cells.
    J Antimicrob Chemother. 2022;77:3496-3503.
    >> Share

  72. MAXWELL DN, Kim J, Pybus CA, White L, et al
    Clinically undetected polyclonal heteroresistance among Pseudomonas aeruginosa isolated from cystic fibrosis respiratory specimens.
    J Antimicrob Chemother. 2022;77:3321-3330.
    >> Share

  73. SPRUTE R, Grothe JH, Heringer S, Cornely OA, et al
    Reason and reality-identifying barriers to patient enrolment for clinical trials in invasive candidiasis.
    J Antimicrob Chemother. 2022;77:3475-3481.
    >> Share

  74. WU YE, Zhao W
    'Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants'-authors' response.
    J Antimicrob Chemother. 2022;77:3525-3526.
    >> Share

  75. CHEN L, Peirano G, Kreiswirth BN, Devinney R, et al
    Acquisition of genomic elements were pivotal for the success of Escherichia coli ST410.
    J Antimicrob Chemother. 2022;77:3399-3407.
    >> Share

  76. PAPAFOTIOU C, Roussos S, Sypsa V, Bampali S, et al
    Predictive score for patients with carbapenemase-producing enterobacterales colonization upon admission in a tertiary care hospital in an endemic area.
    J Antimicrob Chemother. 2022;77:3331-3339.
    >> Share

  77. BIEDRZYCKA M, Izdebski R, Urbanowicz P, Polanska M, et al
    MDR carbapenemase-producing Klebsiella pneumoniae of the hypervirulence-associated ST23 clone in Poland, 2009-19.
    J Antimicrob Chemother. 2022;77:3367-3375.
    >> Share

  78. VIANA AS, Botelho AMN, Feder A, Moustafa AM, et al
    High frequency of increased triclosan MIC among CC5 MRSA and risk of misclassification of the SCCmec into types.
    J Antimicrob Chemother. 2022;77:3340-3348.
    >> Share

  79. ZHANG W, Ran J, Shang L, Zhang L, et al
    Niclosamide as a repurposing drug against Gram-positive bacterial infections.
    J Antimicrob Chemother. 2022;77:3312-3320.
    >> Share

  80. IMANI S, Fitzgerald DA, Robinson PD, Selvadurai H, et al
    Personalized tobramycin dosing in children with cystic fibrosis: a comparative clinical evaluation of log-linear and Bayesian methods.
    J Antimicrob Chemother. 2022;77:3358-3366.
    >> Share

  81. STANDING JF
    Comment on: Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants.
    J Antimicrob Chemother. 2022;77:3524.
    >> Share

  82. HOENIGL M, Lewis R, van de Veerdonk FL, Verweij PE, et al
    Liposomal amphotericin B-the future.
    J Antimicrob Chemother. 2022;77.
    >> Share

  83. BRUGGEMANN RJ, Jensen GM, Lass-Florl C
    Liposomal amphotericin B-the past.
    J Antimicrob Chemother. 2022;77.
    >> Share

  84. MAERTENS J, Pagano L, Azoulay E, Warris A, et al
    Liposomal amphotericin B-the present.
    J Antimicrob Chemother. 2022;77.
    >> Share

  85. GILL CM, Nicolau DP
    Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2022 Nov 22:dkac385. doi: 10.1093.
    >> Share

  86. LALANNE S, Guerin F, Flecher E, Cattoir V, et al
    Diffusion of amoxicillin into heart valves from infective endocarditis patients.
    J Antimicrob Chemother. 2022 Nov 15. pii: 6827952. doi: 10.1093.
    >> Share

  87. SARAVOLATZ LD, Pawlak J
    In vitro activity of fosfomycin alone and in combination against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.
    J Antimicrob Chemother. 2022 Nov 14. pii: 6827318. doi: 10.1093.
    >> Share

  88. SPRUTE R, Van Braeckel E, Flick H, Hoenigl M, et al
    EQUAL CPA Score 2022: a tool to measure guideline adherence for chronic pulmonary aspergillosis.
    J Antimicrob Chemother. 2022 Nov 14. pii: 6827316. doi: 10.1093.
    >> Share

  89. EVANS RN, Harris J, Rogers CA, Macgowan AP, et al
    The effect of duration of therapy for treatment of Staphylococcus aureus blood stream infection: an application of cloning to deal with immortal-time bias in an analysis of data from a cohort study (BSI-FOO).
    J Antimicrob Chemother. 2022 Nov 8. pii: 6811497. doi: 10.1093.
    >> Share

  90. CASTRO BE, Rios R, Carvajal LP, Vargas ML, et al
    Multiomics characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolates with heterogeneous intermediate resistance to vancomycin (hVISA) in Latin America.
    J Antimicrob Chemother. 2022 Nov 2. pii: 6794061. doi: 10.1093.
    >> Share

  91. KELENTSE N, Moyo S, Choga WT, Lechiile K, et al
    High concordance in plasma and CSF HIV-1 drug resistance mutations despite high cases of CSF viral escape in individuals with HIV-associated cryptococcal meningitis in Botswana.
    J Antimicrob Chemother. 2022 Nov 2. pii: 6794066. doi: 10.1093.
    >> Share

    October 2022
  92. TRIPONNEY P, Bour M, Beyrouthy R, Bonnet R, et al
    Role of megaplasmids and chromosomal integration in acquisition of CTX-M-encoding genes by Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2022;77:3194-3198.
    >> Share

  93. WITT LS, Burd EM, Ozturk T, Satola SW, et al
    'Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance'-authors' response.
    J Antimicrob Chemother. 2022;77:3212.
    >> Share

  94. NOTERMANS DW, Schoffelen AF, Landman F, Wielders CCH, et al
    A genetic cluster of OXA-244 carbapenemase-producing Escherichia coli ST38 with putative uropathogenicity factors in the Netherlands.
    J Antimicrob Chemother. 2022;77:3205-3208.
    >> Share

  95. LASKO MJ, Tabor-Rennie JL, Nicolau DP, Kuti JL, et al
    Trimethoprim/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model.
    J Antimicrob Chemother. 2022;77:3187-3193.
    >> Share

  96. HERNANDEZ-GARCIA M, Garcia-Castillo M, Melo-Cristino J, Pinto MF, et al
    In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies).
    J Antimicrob Chemother. 2022;77:3163-3172.
    >> Share

  97. TAM VH, Merlau PR, Hudson CS, Kline EG, et al
    Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022;77:3130-3137.
    >> Share

  98. SUMI CD, Heffernan AJ, Naicker S, Cottrell K, et al
    Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolates.
    J Antimicrob Chemother. 2022;77:3026-3034.
    >> Share

  99. PITT R, Boampong D, Day M, Jensen JS, et al
    Challenges of in vitro propagation and antimicrobial susceptibility testing of Mycoplasma genitalium.
    J Antimicrob Chemother. 2022;77:2901-2907.
    >> Share

  100. ZHAO X, Huang H, Yuan H, Yuan Z, et al
    A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections-authors' response.
    J Antimicrob Chemother. 2022;77:3210-3211.
    >> Share

  101. BRUNA RE, Casal A, Bercovich B, Gramajo H, et al
    A natural product from Streptomyces targets PhoP and exerts antivirulence action against Salmonella enterica.
    J Antimicrob Chemother. 2022;77:3050-3063.
    >> Share

  102. WANG PL, Liu P, Zhang QW, Yuan WH, et al
    Population pharmacokinetics and clinical outcomes of polymyxin B in paediatric patients with multidrug-resistant Gram-negative bacterial infections.
    J Antimicrob Chemother. 2022;77:3000-3008.
    >> Share

  103. PALKOVICOVA J, Sukkar I, Delafuente J, Valcek A, et al
    Fitness effects of blaCTX-M-15-harbouring F2:A1:B- plasmids on their native Escherichia coli ST131 H30Rx hosts.
    J Antimicrob Chemother. 2022;77:2960-2963.
    >> Share

  104. AYFAN AKS, Macdonald J, Irwin AD, Zowawi HM, et al
    Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility.
    J Antimicrob Chemother. 2022;77:2933-2936.
    >> Share

  105. TANG K, Coombs S, Gwee A
    Frequency of drug-induced liver injury in children receiving anti-staphylococcal penicillins.
    J Antimicrob Chemother. 2022 Oct 7. pii: 6751029. doi: 10.1093.
    >> Share

  106. DE JONG A, El Garch F, Hocquet D, Prenger-Berninghoff E, et al
    European-wide antimicrobial resistance monitoring in commensal Escherichia coli isolated from healthy food animals between 2004 and 2018.
    J Antimicrob Chemother. 2022 Oct 7. pii: 6750681. doi: 10.1093.
    >> Share

    September 2022
  107. SHRESTHA R, Luterbach CL, Dai W, Komarow L, et al
    Characteristics of community-acquired carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2022;77:2763-2771.
    >> Share

  108. GROHS P, Vilfaillot A, Zahar JR, Barbut F, et al
    Faecal carriage of multidrug-resistant bacteria and associated risk factors: results from a point prevalence study.
    J Antimicrob Chemother. 2022;77:2667-2678.
    >> Share

  109. BRENCIANI A, Morroni G, Schwarz S, Giovanetti E, et al
    Oxazolidinones: mechanisms of resistance and mobile genetic elements involved.
    J Antimicrob Chemother. 2022;77:2596-2621.
    >> Share

  110. VOLLAND H, Balleste-Delpierre C, Szabo D, Gonzalez C, et al
    Rapid detection of CTX-M-type ESBLs and carbapenemases directly from biological samples using the BL-DetecTool.
    J Antimicrob Chemother. 2022;77:2867-2875.
    >> Share

  111. LONGSHAW CM, Santerre Henriksen A, Slover C, Yamano Y, et al
    Comment on: Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance.
    J Antimicrob Chemother. 2022;77:2895-2896.
    >> Share

  112. PATEL S, Chapagain M, Mason C, Gingrich M, et al
    Potency of the novel PolC DNA polymerase inhibitor CRS0540 in a disseminated Listeria monocytogenes intracellular hollow-fibre model.
    J Antimicrob Chemother. 2022;77:2876-2885.
    >> Share

  113. LASARTE-MONTERRUBIO C, Fraile-Ribot PA, Vazquez-Ucha JC, Cabot G, et al
    Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2022;77:2809-2815.
    >> Share

  114. KADO J, Salman S, Hand R, O'Brien M, et al
    Population pharmacokinetic study of benzathine penicillin G administration in Indigenous children and young adults with rheumatic heart disease in the Northern Territory, Australia.
    J Antimicrob Chemother. 2022;77:2679-2682.
    >> Share

  115. DE LAUZANNE A, Sreng N, Foucaud E, Sok T, et al
    Prevalence and factors associated with faecal carriage of extended-spectrum beta-lactamase-producing Enterobacterales among peripartum women in the community in Cambodia.
    J Antimicrob Chemother. 2022;77:2658-2666.
    >> Share

  116. DIAS SA, Pinto SN, Silva-Herdade AS, Cheneval O, et al
    A designed cyclic analogue of gomesin has potent activity against Staphylococcus aureus biofilms.
    J Antimicrob Chemother. 2022 Sep 29. pii: 6728340. doi: 10.1093.
    >> Share

  117. LI J, Fan Q, Zuo J, Xue B, et al
    Paeoniflorin combined with norfloxacin ameliorates drug-resistant Streptococcus suis infection.
    J Antimicrob Chemother. 2022 Sep 28. pii: 6730836. doi: 10.1093.
    >> Share

  118. RAMPACCI E, Felicetti T, Pietrella D, Sabatini S, et al
    Drug efflux transporters in Staphylococcus pseudintermedius: in silico prediction and characterization of resistance.
    J Antimicrob Chemother. 2022 Sep 28. pii: 6730837. doi: 10.1093.
    >> Share

  119. MELENDEZ-CARMONA MA, Mancheno-Losa M, Ruiz-Sorribas A, Munoz-Gallego I, et al
    Strain-to-strain variability among Staphylococcus aureus causing prosthetic joint infection drives heterogeneity in response to levofloxacin and rifampicin.
    J Antimicrob Chemother. 2022 Sep 19. pii: 6704758. doi: 10.1093.
    >> Share

  120. COLOMBO AL, De Almeida JN, Lewis RE, Kontoyiannis DP, et al
    Quandaries of deciding when to change first-line therapy in invasive pulmonary aspergillosis.
    J Antimicrob Chemother. 2022 Sep 5. pii: 6691804. doi: 10.1093.
    >> Share

  121. RIGATTO MH, Ramos F, Barros A, Pedroso S, et al
    Double-, single- and none-carbapenem-containing regimens for the treatment of carbapenem-resistant Enterobacterales (CRE) bloodstream infections: a retrospective cohort.
    J Antimicrob Chemother. 2022 Sep 1. pii: 6681124. doi: 10.1093.
    >> Share

    August 2022
  122. DIAZ-GARCIA J, Gomez A, Machado M, Alcala L, et al
    Blood and intra-abdominal Candida spp. from a multicentre study conducted in Madrid using EUCAST: emergence of fluconazole resistance in Candida parapsilosis, low echinocandin resistance and absence of Candida auris.
    J Antimicrob Chemother. 2022 Aug 29. pii: 6678135. doi: 10.1093.
    >> Share

  123. KONG FYS, Lo FWY, Hocking JS
    Treatment efficacy for rectal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials-authors' response.
    J Antimicrob Chemother. 2022;77:2576-2577.
    >> Share

  124. GONZALEZ-DIAZ A, Berbel D, Ercibengoa M, Cercenado E, et al
    Genomic features of predominant non-PCV13 serotypes responsible for adult invasive pneumococcal disease in Spain.
    J Antimicrob Chemother. 2022;77:2389-2398.
    >> Share

  125. YAMADA K, Yoshizumi A, Nagasawa T, Aoki K, et al
    Molecular and biochemical characterization of novel PAM-like MBL variants, PAM-2 and PAM-3, from clinical isolates of Pseudomonas tohonis.
    J Antimicrob Chemother. 2022;77:2414-2418.
    >> Share

  126. PATERSON DL, Bassetti M, Motyl M, Johnson MG, et al
    Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial.
    J Antimicrob Chemother. 2022;77:2522-2531.
    >> Share

  127. MULLALLY C, Stubbs KA, Thai VC, Anandan A, et al
    Novel small molecules that increase the susceptibility of Neisseria gonorrhoeae to cationic antimicrobial peptides by inhibiting lipid A phosphoethanolamine transferase.
    J Antimicrob Chemother. 2022;77:2441-2447.
    >> Share

  128. PECHACEK J, Yakubu I, Vissichelli NC, Bruno D, et al
    Successful expanded access use of rezafungin, a novel echinocandin, to eradicate refractory invasive candidiasis in a liver transplant recipient.
    J Antimicrob Chemother. 2022;77:2571-2573.
    >> Share

  129. YANG F, Gao S, Yan J, Lin X, et al
    Moenomycin is broadly active against multidrug-resistant Neisseria gonorrhoeae and clears an infection from a murine vaginal tract infection model.
    J Antimicrob Chemother. 2022;77:2461-2469.
    >> Share

  130. PARET R, Le Bourgeois A, Guillerm G, Tessoulin B, et al
    Safety and risk of febrile recurrence after early antibiotic discontinuation in high-risk neutropenic patients with haematological malignancies: a multicentre observational study.
    J Antimicrob Chemother. 2022;77:2546-2556.
    >> Share

  131. HSU YP, Chen LF, Chen FL, Liu YK, et al
    Comment on: Treatment efficacy for rectal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials.
    J Antimicrob Chemother. 2022;77:2574-2576.
    >> Share

  132. WILSON RC, Arkell P, Riezk A, Gilchrist M, et al
    Addition of probenecid to oral beta-lactam antibiotics: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2022;77:2364-2372.
    >> Share

  133. WITT LS, Steed DB, Burd EM, Ozturk T, et al
    Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance.
    J Antimicrob Chemother. 2022;77:2569-2571.
    >> Share

  134. ISLAM K, Sime FB, Wallis SC, Bauer MJ, et al
    Pharmacodynamic evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum beta-lactamase-producing and non-producing Escherichia coli clinical isolates in a hollow-fibre infection model.
    J Antimicrob Chemother. 2022;77:2448-2455.
    >> Share

  135. YOON CH, Bartlett S, Stoesser N, Pouwels KB, et al
    Mortality risks associated with empirical antibiotic activity in Escherichia coli bacteraemia: an analysis of electronic health records.
    J Antimicrob Chemother. 2022;77:2536-2545.
    >> Share

  136. ZHAO L, Liu A, Li R, Zhang Z, et al
    High prevalence of blaTEM-135 and genetic epidemiology of blaTEM-135-carrying Neisseria gonorrhoeae isolates in Shandong, China, 2017-19.
    J Antimicrob Chemother. 2022;77:2406-2413.
    >> Share

  137. DANJOU W, Chabert P, Perpoint T, Pradat P, et al
    Necrotizing external otitis: analysis of relapse risk factors in 66 patients managed during a 12 year period.
    J Antimicrob Chemother. 2022;77:2532-2535.
    >> Share

  138. WANG G, Wu P, Tang R, Zhang W, et al
    Global prevalence of resistance to macrolides in Mycoplasma pneumoniae: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2022;77:2353-2363.
    >> Share

  139. NUESCH-INDERBINEN M, Biggel M, Zurfluh K, Treier A, et al
    Faecal carriage of enterococci harbouring oxazolidinone resistance genes among healthy humans in the community in Switzerland.
    J Antimicrob Chemother. 2022 Aug 16. pii: 6667639. doi: 10.1093.
    >> Share

  140. FONG W, Timms V, Sim E, Pey K, et al
    Genomic and transcriptomic variation in Bordetella spp. following induction of erythromycin resistance.
    J Antimicrob Chemother. 2022 Aug 16. pii: 6667673. doi: 10.1093.
    >> Share

  141. ESCOLA-VERGE L, Rello P, Declerck C, Dubee V, et al
    Infective endocarditis in pregnant women without intravenous drug use: a multicentre retrospective case series.
    J Antimicrob Chemother. 2022 Aug 13. pii: 6664295. doi: 10.1093.
    >> Share

    July 2022
  142. ROGERS TR, Verweij PE, Castanheira M, Dannaoui E, et al
    Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications.
    J Antimicrob Chemother. 2022;77:2053-2073.
    >> Share

  143. GASTINE S, Hempel G, Neely MN, Walsh TJ, et al
    Pharmacokinetic modelling of caspofungin to develop an extended dosing regimen in paediatric patients.
    J Antimicrob Chemother. 2022;77:2209-2216.
    >> Share

  144. SALLEM N, Hammami A, Mnif B
    Trends in human intestinal carriage of ESBL- and carbapenemase-producing Enterobacterales among food handlers in Tunisia: emergence of C1-M27-ST131 subclades, blaOXA-48 and blaNDM.
    J Antimicrob Chemother. 2022;77:2142-2152.
    >> Share

  145. KAKU N, Sasaki D, Ota K, Miyazaki T, et al
    Changing molecular epidemiology and characteristics of MRSA isolated from bloodstream infections: nationwide surveillance in Japan in 2019.
    J Antimicrob Chemother. 2022;77:2130-2141.
    >> Share

  146. CHUANG YC, Lin HY, Yang JL, Lin CY, et al
    Influence of daptomycin doses on the outcomes of VRE bloodstream infection treated with high-dose daptomycin.
    J Antimicrob Chemother. 2022;77:2278-2287.
    >> Share

  147. CHEN L, van Rhee KP, Wasmann RE, Krekels EHJ, et al
    Total bodyweight and sex both drive pharmacokinetic variability of fluconazole in obese adults.
    J Antimicrob Chemother. 2022;77:2217-2226.
    >> Share

  148. ROSCA AS, Castro J, Sousa LGV, Franca A, et al
    In vitro interactions within a biofilm containing three species found in bacterial vaginosis (BV) support the higher antimicrobial tolerance associated with BV recurrence.
    J Antimicrob Chemother. 2022;77:2183-2190.
    >> Share

  149. KUFEL WD, Abouelhassan Y, Steele JM, Gutierrez RL, et al
    Plasma and cerebrospinal fluid concentrations of cefiderocol during successful treatment of carbapenem-resistant Acinetobacter baumannii meningitis.
    J Antimicrob Chemother. 2022 Jul 23. pii: 6648989. doi: 10.1093.
    >> Share

  150. BUIS DTP, Prins JM, Betica-Radic L, de Boer MGJ, et al
    Current clinical practice in antibiotic treatment of Staphylococcus aureus bacteraemia: results from a survey in five European countries.
    J Antimicrob Chemother. 2022 Jul 23. pii: 6648977. doi: 10.1093.
    >> Share

  151. SEALEY JE, Hammond A, Mounsey O, Gould VC, et al
    Molecular ecology and risk factors for third-generation cephalosporin-resistant Escherichia coli carriage by dogs living in urban and nearby rural settings.
    J Antimicrob Chemother. 2022 Jul 20. pii: 6645196. doi: 10.1093.
    >> Share

  152. CHEN T, Zhao L, Liu Y, Wang Y, et al
    Mechanisms of high-level fosfomycin resistance in Staphylococcus aureus epidemic lineage ST5.
    J Antimicrob Chemother. 2022 Jul 15. pii: 6644783. doi: 10.1093.
    >> Share

  153. EMERAUD C, Godmer A, Girlich D, Vanparis O, et al
    Activity of mecillinam against carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2022 Jul 11. pii: 6639593. doi: 10.1093.
    >> Share

    June 2022
  154. TURNER NA, Xu A, Zaharoff S, Holland TL, et al
    Determination of plasma protein binding of dalbavancin.
    J Antimicrob Chemother. 2022;77:1899-1902.
    >> Share

  155. CHUMBITA M, Puerta-Alcalde P, Yanez L, Cuesta MA, et al
    Resistance to empirical beta-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study.
    J Antimicrob Chemother. 2022;77:2017-2023.
    >> Share

  156. TORRENS G, van der Schalk TE, Cortes-Lara S, Timbermont L, et al
    Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial.
    J Antimicrob Chemother. 2022;77:1862-1872.
    >> Share

  157. GOMEZ-SIMMONDS A, Annavajhala MK, Tang N, Rozenberg FD, et al
    Population structure of blaKPC-harbouring IncN plasmids at a New York City medical centre and evidence for multi-species horizontal transmission.
    J Antimicrob Chemother. 2022;77:1873-1882.
    >> Share

  158. ONG JJ, Aguirre I, Unemo M, Kong FYS, et al
    Comparison of gastrointestinal side effects from different doses of azithromycin for the treatment of gonorrhoea.
    J Antimicrob Chemother. 2022;77:2011-2016.
    >> Share

  159. ESCUDERO-SANCHEZ R, Muriel Garcia A, Garcia Fernandez S, Valencia Alijo A, et al
    Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study.
    J Antimicrob Chemother. 2022;77:1996-2002.
    >> Share

  160. DARLOW CA, Hope W
    Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales-authors' response.
    J Antimicrob Chemother. 2022;77:2047-2048.
    >> Share

  161. STANDING JF
    Comment on: Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales.
    J Antimicrob Chemother. 2022;77:2046-2047.
    >> Share

  162. KAUL G, Akhir A, Shukla M, Rawat KS, et al
    Nitazoxanide potentiates linezolid against linezolid-resistant Staphylococcus aureus in vitro and in vivo.
    J Antimicrob Chemother. 2022 Jun 24. pii: 6617327. doi: 10.1093.
    >> Share

  163. IQBAL K, Rohde H, Huang J, Tikiso T, et al
    A pharmacokinetic-pharmacodynamic (PKPD) model-based analysis of tedizolid against enterococci using the hollow-fibre infection model.
    J Antimicrob Chemother. 2022 Jun 13. pii: 6607739. doi: 10.1093.
    >> Share

  164. GAUSI K, Chirehwa M, Ignatius EH, Court R, et al
    Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis.
    J Antimicrob Chemother. 2022 Jun 9. pii: 6604654. doi: 10.1093.
    >> Share

    May 2022
  165. VUILLEMENOT JB, Bour M, Beyrouthy R, Bonnet R, et al
    Genomic analysis of CTX-M-115 and OXA-23/-72 co-producing Acinetobacter baumannii, and their potential to spread resistance genes by natural transformation.
    J Antimicrob Chemother. 2022;77:1542-1552.
    >> Share

  166. GAIBANI P, Bovo F, Bussini L, Lazzarotto T, et al
    Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments.
    J Antimicrob Chemother. 2022;77:1570-1577.
    >> Share

  167. PORMOHAMMAD A, Greening D, Turner RJ
    Synergism inhibition and eradication activity of silver nitrate/potassium tellurite combination against Pseudomonas aeruginosa biofilm.
    J Antimicrob Chemother. 2022;77:1635-1644.
    >> Share

  168. SPRUTE R, Bethe U, Chen SC, Cornely OA, et al
    EQUAL Trichosporon Score 2022: an ECMM score to measure QUALity of the clinical management of invasive Trichosporon infections.
    J Antimicrob Chemother. 2022;77:1779-1784.
    >> Share

  169. NAHA S, Sands K, Mukherjee S, Dutta S, et al
    A 12 year experience of colistin resistance in Klebsiella pneumoniae causing neonatal sepsis: two-component systems, efflux pumps, lipopolysaccharide modification and comparative phylogenomics.
    J Antimicrob Chemother. 2022;77:1586-1591.
    >> Share

  170. CABRERA R, Fernandez-Barat L, Vazquez N, Alcaraz-Serrano V, et al
    Resistance mechanisms and molecular epidemiology of Pseudomonas aeruginosa strains from patients with bronchiectasis.
    J Antimicrob Chemother. 2022;77:1600-1610.
    >> Share

  171. YEOH DK, Haeusler GM, McMullan BJ, Butters C, et al
    Antifungal use in children with acute leukaemia: state of current evidence and directions for future research.
    J Antimicrob Chemother. 2022;77:1508-1524.
    >> Share

  172. IZDEBSKI R, Biedrzycka M, Urbanowicz P, Papierowska-Kozdoj W, et al
    Multiple secondary outbreaks of NDM-producing Enterobacter hormaechei in the context of endemic NDM-producing Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022;77:1561-1569.
    >> Share

  173. JAUNEIKAITE E, Honeyford K, Blandy O, Mosavie M, et al
    Bacterial genotypic and patient risk factors for adverse outcomes in Escherichia coli bloodstream infections: a prospective molecular epidemiological study.
    J Antimicrob Chemother. 2022;77:1753-1761.
    >> Share

  174. CHAPAGAIN M, Pasipanodya JG, Athale S, Bernal C, et al
    Omadacycline efficacy in the hollow fibre system model of pulmonary Mycobacterium avium complex and potency at clinically attainable doses.
    J Antimicrob Chemother. 2022;77:1694-1705.
    >> Share

  175. LUQUE-PAZ D, Bennis Y, Jaubert P, Dubee V, et al
    Cerebrospinal fluid concentrations of cefiderocol during the treatment of extensively drug-resistant Pseudomonas aeruginosa ventriculitis.
    J Antimicrob Chemother. 2022;77:1787-1789.
    >> Share

  176. SAKOULAS G
    Linezolid versus omadacycline in diabetic soft tissue infections: a signal of different adjunctive immunological properties?
    J Antimicrob Chemother. 2022;77:1503-1505.
    >> Share

  177. IWUJI C, Pillay D, Shamu P, Murire M, et al
    A systematic review of antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium in sub-Saharan Africa.
    J Antimicrob Chemother. 2022 May 17. pii: 6586623. doi: 10.1093.
    >> Share

  178. WILLEKENS R, Puig-Asensio M, Suanzes P, Fernandez-Hidalgo N, et al
    Empirical use of beta-lactam/beta-lactamase inhibitor combinations does not increase mortality compared with cloxacillin and cefazolin in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-weighted cohort study.
    J Antimicrob Chemother. 2022 May 12. pii: 6584695. doi: 10.1093.
    >> Share

  179. GOLPARIAN D, Kittiyaowamarn R, Paopang P, Sangprasert P, et al
    Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018.
    J Antimicrob Chemother. 2022 May 11. pii: 6583486. doi: 10.1093.
    >> Share

    April 2022
  180. FLATEAU C, Riazi A, Cassard B, Camus M, et al
    Streptococcal and enterococcal endocarditis: time for individualized antibiotherapy?-authors' response.
    J Antimicrob Chemother. 2022 Apr 27. pii: 6574660. doi: 10.1093.
    >> Share

  181. GARCIA-FIERRO R, Drapeau A, Dazas M, Saras E, et al
    Comparative phylogenomics of ESBL-, AmpC- and carbapenemase-producing Klebsiella pneumoniae originating from companion animals and humans.
    J Antimicrob Chemother. 2022;77:1263-1271.
    >> Share

  182. ABBOTT IJ, van Gorp E, Wyres KL, Wallis SC, et al
    Oral fosfomycin activity against Klebsiella pneumoniae in a dynamic bladder infection in vitro model.
    J Antimicrob Chemother. 2022;77:1324-1333.
    >> Share

  183. MILTGEN G, Martak D, Valot B, Kamus L, et al
    One Health compartmental analysis of ESBL-producing Escherichia coli on Reunion Island reveals partitioning between humans and livestock.
    J Antimicrob Chemother. 2022;77:1254-1262.
    >> Share

  184. BASTIDA C, Hernandez-Tejero M, Cariqueo M, Aziz F, et al
    Tigecycline population pharmacokinetics in critically ill patients with decompensated cirrhosis and severe infections.
    J Antimicrob Chemother. 2022;77:1365-1371.
    >> Share

  185. MEI CY, Jiao X, Wu H, Wang ZY, et al
    Detection of cfr in Leclercia adecarboxylata from pig feed, China.
    J Antimicrob Chemother. 2022;77:1500-1502.
    >> Share

  186. ZHANG X, Shi S, Yao Z, Zheng X, et al
    Antimicrobial peptide WAM-1: a promising antibacterial and anti-inflammatory drug against carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022 Apr 27. pii: 6574685. doi: 10.1093.
    >> Share

  187. TAIT JR, Barnett TC, Rogers KE, Lee WL, et al
    Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling.
    J Antimicrob Chemother. 2022 Apr 26. pii: 6573986. doi: 10.1093.
    >> Share

  188. LOPEZ-VARELA E, Abulfathi AA, Strydom N, Goussard P, et al
    Drug concentration at the site of disease in children with pulmonary tuberculosis.
    J Antimicrob Chemother. 2022 Apr 25. pii: 6573919. doi: 10.1093.
    >> Share

  189. CHAGNEAU CV, Alcouffe O, Grare M, Oswald E, et al
    Screening for beta-lactam resistance by penicillin G in the Streptococcus anginosus group challenged by rare strains with altered PBPs.
    J Antimicrob Chemother. 2022 Apr 25. pii: 6573466. doi: 10.1093.
    >> Share

  190. ENER B, Ergin C, Gulmez D, Agca H, et al
    Frequency of azole resistance in clinical and environmental strains of Aspergillus fumigatus in Turkey: a multicentre study.
    J Antimicrob Chemother. 2022 Apr 21. pii: 6571734. doi: 10.1093.
    >> Share

  191. SCHWENDENER S, Perreten V
    The bla and mec families of beta-lactam resistance genes in the genera Macrococcus, Mammaliicoccus and Staphylococcus: an in-depth analysis with emphasis on Macrococcus.
    J Antimicrob Chemother. 2022 Apr 21. pii: 6571732. doi: 10.1093.
    >> Share

  192. LIU C, Dong N, Zeng Y, Lu J, et al
    Co-transfer of last-line antibiotic resistance and virulence operons by an IncFIBk-FII-X3-ColKP3 hybrid plasmid in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022 Apr 21. pii: 6571571. doi: 10.1093.
    >> Share

  193. SIMOS PA, Holland DJ, Stewart A, Isler B, et al
    Clinical prediction scores and the utility of time to blood culture positivity in stratifying the risk of infective endocarditis in Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2022 Apr 15. pii: 6568605. doi: 10.1093.
    >> Share

  194. CORTES MF, Andre C, Martins Simoes P, Corvec S, et al
    Persistence of a multidrug-resistant worldwide-disseminated methicillin-resistant Staphylococcus epidermidis clone harbouring the cfr linezolid resistance gene in a French hospital with evidence of interspecies transfer to several Staphylococcus aureu
    J Antimicrob Chemother. 2022 Apr 15. pii: 6568602. doi: 10.1093.
    >> Share

  195. FUCHS F, Becerra-Aparicio F, Xanthopoulou K, Seifert H, et al
    In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract.
    J Antimicrob Chemother. 2022 Apr 12. pii: 6566767. doi: 10.1093.
    >> Share

  196. HARMER CJ, Lebreton F, Stam J, McGann PT, et al
    Complete genome of the extensively antibiotic-resistant GC1 Acinetobacter baumannii isolate MRSN 56 reveals a novel route to fluoroquinolone resistance.
    J Antimicrob Chemother. 2022 Apr 11. pii: 6566059. doi: 10.1093.
    >> Share

  197. GIULIANO S, Angelini J, Flammini S, Tascini C, et al
    Comment on: Streptococcal and enterococcal endocarditis: time for individualized antibiotherapy?
    J Antimicrob Chemother. 2022 Apr 4. pii: 6562960. doi: 10.1093.
    >> Share

  198. CHAIBEN V, Yamada CH, Telles JP, de Andrade AP, et al
    A carbapenem-resistant Acinetobacter baumannii outbreak associated with a polymyxin shortage during the COVID pandemic: an in vitro and biofilm analysis of synergy between meropenem, gentamicin and sulbactam.
    J Antimicrob Chemother. 2022 Apr 4. pii: 6562691. doi: 10.1093.
    >> Share

    March 2022
  199. BIEZ L, Bonnin RA, Naas T, Dortet L, et al
    Characterization of VIM-1-, NDM-1- and OXA-48-producing Citrobacter freundii in France.
    J Antimicrob Chemother. 2022;77:1200-1202.
    >> Share

  200. MUDDE SE, Upton AM, Lenaerts A, Bax HI, et al
    Delamanid or pretomanid? A Solomonic judgement!
    J Antimicrob Chemother. 2022;77:880-902.
    >> Share

  201. GOMIS-FONT MA, Cabot G, Lopez-Arguello S, Zamorano L, et al
    Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones.
    J Antimicrob Chemother. 2022;77:957-968.
    >> Share

  202. PANT N, Wallis SC, Roberts JA, Eisen DP, et al
    In vitro effect of synovial fluid from patients undergoing arthroplasty surgery on MRSA biofilm formation.
    J Antimicrob Chemother. 2022;77:1041-1044.
    >> Share

  203. EMERAUD C, Petit C, Gauthier L, Bonnin RA, et al
    Emergence of VIM-producing Enterobacter cloacae complex in France between 2015 and 2018.
    J Antimicrob Chemother. 2022;77:944-951.
    >> Share

  204. REYNOLDS R, Mushtaq S, Allen MK, Horner C, et al
    Impact of changed co-amoxiclav susceptibility testing formats on apparent resistance rates for bloodstream Escherichia coli in a long-term surveillance.
    J Antimicrob Chemother. 2022;77:1206-1208.
    >> Share

  205. FALCONE M, Tiseo G, Arcari G, Leonildi A, et al
    Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: an observational study from Italy, 2020-21.
    J Antimicrob Chemother. 2022;77:1140-1145.
    >> Share

  206. WANG W, Hu Y, Baker M, Dottorini T, et al
    Novel SCCmec type XV (7A) and two pseudo-SCCmec variants in foodborne MRSA in China.
    J Antimicrob Chemother. 2022;77:903-909.
    >> Share

  207. LI D, Li P, Peng M, Zhao X, et al
    Transmission barrier of the blaKPC plasmid mediated by type I restriction-modification systems in Escherichia coli.
    J Antimicrob Chemother. 2022;77:952-956.
    >> Share

  208. MAGALLON A, Amoureux L, Garrigos T, Sonois M, et al
    Role of AxyABM overexpression in acquired resistance in Achromobacter xylosoxidans.
    J Antimicrob Chemother. 2022;77:926-929.
    >> Share

  209. MARTIN-LOECHES I, Timsit JF, Kollef MH, Wunderink RG, et al
    Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia.
    J Antimicrob Chemother. 2022;77:1166-1177.
    >> Share

  210. VEHRESCHILD MJGT, Ducher A, Louie T, Cornely OA, et al
    An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones.
    J Antimicrob Chemother. 2022;77:1155-1165.
    >> Share

  211. TICKNER JA, Bradshaw CS, Murray GL, Whiley DM, et al
    Novel probe-based melting curve assays for the characterization of fluoroquinolone resistance in Mycoplasma genitalium.
    J Antimicrob Chemother. 2022 Mar 30. pii: 6555777. doi: 10.1093.
    >> Share

  212. LIANG J, Macesic N, Blakeway L
    Comment on: Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?
    J Antimicrob Chemother. 2022 Mar 24. pii: 6553323. doi: 10.1093.
    >> Share

  213. GEORGIOU PC, Arendrup MC, Meletiadis J
    Early phenotypic detection of fluconazole- and anidulafungin-resistant Candida glabrata isolates.
    J Antimicrob Chemother. 2022 Mar 22. pii: 6551886. doi: 10.1093.
    >> Share

  214. KIRCHHOFF L, Dittmer S, Furnica DT, Buer J, et al
    Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim.
    J Antimicrob Chemother. 2022 Mar 15. pii: 6548677. doi: 10.1093.
    >> Share

  215. CREMANNS M, Lange F, Gatermann SG, Pfennigwerth N, et al
    Effect of sigma E on carbapenem resistance in OXA-48-producing Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022 Mar 10. pii: 6546017. doi: 10.1093.
    >> Share

  216. BATESON A, Ortiz Canseco J, McHugh TD, Witney AA, et al
    Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid.
    J Antimicrob Chemother. 2022 Mar 9. pii: 6544883. doi: 10.1093.
    >> Share

  217. UPTON CM, Steele CI, Maartens G, Diacon AH, et al
    Pharmacokinetics of bedaquiline in cerebrospinal fluid (CSF) in patients with pulmonary tuberculosis (TB).
    J Antimicrob Chemother. 2022 Mar 8. pii: 6543975. doi: 10.1093.
    >> Share

  218. NEVILLE LF, Shalit I, Warn PA, Rendell JT, et al
    Vancomycin-arginine (STM-001) abrogates ESBL carrier and carbapenem-resistant Escherichia coli burden in a murine complicated urinary tract infection model.
    J Antimicrob Chemother. 2022 Mar 1. pii: 6539950. doi: 10.1093.
    >> Share

    February 2022
  219. MELETIADIS J, Efstathiou I, van der Lee HAL, Astvad KMT, et al
    Spectrophotometric detection of azole-resistant Aspergillus fumigatus with the EUCAST broth microdilution method: is it time for automated MIC reading of EUCAST antifungal susceptibility testing of Aspergillus species?
    J Antimicrob Chemother. 2022 Feb 23. pii: 6534628. doi: 10.1093.
    >> Share

  220. BAE M, Jung J
    Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study-authors' response.
    J Antimicrob Chemother. 2022;77:859-860.
    >> Share

  221. BURY D, Wolfs TFW, Ter Heine R, Muilwijk EW, et al
    Pharmacokinetic evaluation of twice-a-week micafungin for prophylaxis of invasive fungal disease in children with acute lymphoblastic leukaemia: a prospective observational cohort study.
    J Antimicrob Chemother. 2022;77:699-703.
    >> Share

  222. FOSTERVOLD A, Hetland MAK, Bakksjo R, Bernhoff E, et al
    A nationwide genomic study of clinical Klebsiella pneumoniae in Norway 2001-15: introduction and spread of ESBLs facilitated by clonal groups CG15 and CG307.
    J Antimicrob Chemother. 2022;77:665-674.
    >> Share

  223. ALIABADI S, Jauneikaite E, Muller-Pebody B, Hope R, et al
    Exploring temporal trends and risk factors for resistance in Escherichia coli-causing bacteraemia in England between 2013 and 2018: an ecological study.
    J Antimicrob Chemother. 2022;77:782-792.
    >> Share

  224. HAGIYA H, Otsuka F
    Comment on: Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study.
    J Antimicrob Chemother. 2022;77:857-858.
    >> Share

  225. MARTELLI F, AbuOun M, Cawthraw S, Storey N, et al
    Detection of the transferable tigecycline resistance gene tet(X4) in Escherichia coli from pigs in the United Kingdom.
    J Antimicrob Chemother. 2022;77:846-848.
    >> Share

  226. LUO H, Chen W, Mai Z, Yang J, et al
    Development and application of Cas13a-based diagnostic assay for Neisseria gonorrhoeae detection and azithromycin resistance identification.
    J Antimicrob Chemother. 2022;77:656-664.
    >> Share

  227. FIFER H, Schaefer U, Pitt R, Allen H, et al
    Use of genomics to investigate Neisseria gonorrhoeae antimicrobial susceptibility testing discrepancies.
    J Antimicrob Chemother. 2022;77:849-850.
    >> Share

  228. KELLY J, Tysall L, Dewar S
    Daptomycin susceptibility testing and therapeutic use in enterococcal bloodstream infection (EBSI) in a setting with high rates of vancomycin-resistant Enterococcus faecium (VREfm).
    J Antimicrob Chemother. 2022 Feb 15. pii: 6528651. doi: 10.1093.
    >> Share

  229. CHUANG YC, Tseng TC, Wang JT, Lin CY, et al
    Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination.
    J Antimicrob Chemother. 2022 Feb 10. pii: 6525717. doi: 10.1093.
    >> Share

  230. GOLDEN AR, Baxter M, Adam HJ, Martin I, et al
    PCV-15 and PPSV-23 coverage of invasive and respiratory tract Streptococcus pneumoniae, including MDR and XDR isolates: CANWARD 2007-20.
    J Antimicrob Chemother. 2022 Feb 10. pii: 6525856. doi: 10.1093.
    >> Share

  231. XU C, Wang N, Li D, Schwarz S, et al
    Recombination events that occur in a poxtA-carrying Enterococcus faecium during the conjugation process.
    J Antimicrob Chemother. 2022 Feb 8. pii: 6524123. doi: 10.1093.
    >> Share

  232. COCCITTO SN, Cinthi M, Fioriti S, Morroni G, et al
    Linezolid-resistant Enterococcus gallinarum isolate of swine origin carrying cfr, optrA and poxtA genes.
    J Antimicrob Chemother. 2022;77:331-337.
    >> Share

  233. MARR I, Swe K, Henderson A, Lacey JA, et al
    Cefazolin susceptibility of coagulase-negative staphylococci (CoNS) causing late-onset neonatal bacteraemia.
    J Antimicrob Chemother. 2022;77:338-344.
    >> Share

  234. EGAN SA, Kavanagh NL, Shore AC, Mollerup S, et al
    Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland.
    J Antimicrob Chemother. 2022;77:320-330.
    >> Share

  235. WASSERMAN S, Brust JCM, Abdelwahab MT, Little F, et al
    Linezolid toxicity in patients with drug-resistant tuberculosis: a prospective cohort study.
    J Antimicrob Chemother. 2022 Feb 2. pii: 6520540. doi: 10.1093.
    >> Share

  236. SCHUSTER CF, Weber RE, Weig M, Werner G, et al
    Ultra-deep long-read sequencing detects IS-mediated gene duplications as a potential trigger to generate arrays of resistance genes and a mechanism to induce novel gene variants such as blaCTX-M-243.
    J Antimicrob Chemother. 2022;77:381-390.
    >> Share

  237. GUO CG, Jiang F, Cheung KS, Li B, et al
    Timing of prior exposure to antibiotics and failure of Helicobacter pylori eradication: a population-based study.
    J Antimicrob Chemother. 2022;77:517-523.
    >> Share

  238. KANESAKA I, Ohno A, Katsuse AK, Takahashi H, et al
    The emergence of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone by transfer of resistance from an oral Neisseria subflava reservoir of resistance.
    J Antimicrob Chemother. 2022;77:364-373.
    >> Share

  239. LIN EY, Adamson PC, Klausner JD
    Applying molecular algorithms to predict decreased susceptibility to ceftriaxone from a report of strains of Neisseria gonorrhoeae in Amsterdam, the Netherlands.
    J Antimicrob Chemother. 2022;77:534-536.
    >> Share

    January 2022
  240. AMBROSE SJ, Evans BA, Hall RM
    Origin of the oxa235 carbapenem resistance gene found in transposon Tn6252.
    J Antimicrob Chemother. 2022 Jan 30. pii: 6517523. doi: 10.1093.
    >> Share

  241. KIESWETTER NS, Ozturk M, Hlaka L, Chia JE, et al
    Intranasally administered S-MGB-364 displays antitubercular activity and modulates the host immune response to Mycobacterium tuberculosis infection.
    J Antimicrob Chemother. 2022 Jan 25. pii: 6515318. doi: 10.1093.
    >> Share

  242. ZOU G, Matuszewska M, Bai F, Wang S, et al
    Genomic analyses of Staphylococcus aureus isolated from yaks in Ganzi Tibetan Autonomous Prefecture, China.
    J Antimicrob Chemother. 2022 Jan 25. pii: 6515324. doi: 10.1093.
    >> Share

  243. FRENK S, Temkin E, Lurie-Weinberger MN, Keren-Paz A, et al
    Large-scale WGS of carbapenem-resistant Acinetobacter baumannii isolates reveals patterns of dissemination of ST clades associated with antibiotic resistance.
    J Antimicrob Chemother. 2022 Jan 25. pii: 6515327. doi: 10.1093.
    >> Share

  244. SEMPERE J, Gonzalez-Camacho F, Domenech M, Llamosi M, et al
    A national longitudinal study evaluating the activity of cefditoren and other antibiotics against non-susceptible Streptococcus pneumoniae strains during the period 2004-20 in Spain.
    J Antimicrob Chemother. 2022 Jan 19. pii: 6511705. doi: 10.1093.
    >> Share

  245. PAUNKOV A, Gutenbrunner K, Soki J, Leitsch D, et al
    Haemin deprivation renders Bacteroides fragilis hypersusceptible to metronidazole and cancels high-level metronidazole resistance.
    J Antimicrob Chemother. 2022 Jan 18. pii: 6510936. doi: 10.1093.
    >> Share

  246. MANTZOURANI E, Cannings-John R, Evans A, Ahmed H, et al
    To swab or not to swab? Using point-of-care tests to detect Group A Streptococcus infections as part of a Sore Throat Test and Treat service in community pharmacy.
    J Antimicrob Chemother. 2022 Jan 17. pii: 6509366. doi: 10.1093.
    >> Share

  247. GWEE A, Duffull SB, Daley AJ, Lim M, et al
    Identifying a therapeutic target for vancomycin against staphylococci in young infants.
    J Antimicrob Chemother. 2022 Jan 17. pii: 6509364. doi: 10.1093.
    >> Share

  248. THILL P, Robineau O, Roosen G, Patoz P, et al
    Rifabutin versus rifampicin bactericidal and antibiofilm activities against clinical strains of Staphylococcus spp. isolated from bone and joint infections.
    J Antimicrob Chemother. 2022 Jan 13. pii: 6506691. doi: 10.1093.
    >> Share

  249. GAILLARD T, Dupieux-Chabert C, Butin M, Dumitrescu O, et al
    Heterogeneous vancomycin resistance in Staphylococcus aureus does not predict development of vancomycin resistance upon vancomycin pressure.
    J Antimicrob Chemother. 2022 Jan 11. pii: 6503862. doi: 10.1093.
    >> Share

    December 2021
  250. KLAUKE P, Schwab F, Gastmeier P, Maechler F, et al
    The impact of non-antimicrobial drug agents on the acquisition of ESBL-producing Enterobacterales in non-critical care wards in a German university hospital: an exploratory, matched case-control study.
    J Antimicrob Chemother. 2021;77:229-236.
    >> Share

  251. FISCHER N, Maex M, Mattheus W, Van den Bossche A, et al
    Genomic epidemiology of persistently circulating MDR Shigella sonnei strains associated with men who have sex with men (MSM) in Belgium (2013-19).
    J Antimicrob Chemother. 2021;77:89-97.
    >> Share

  252. TIMMERMANS M, Bogaerts B, Vanneste K, De Keersmaecker SCJ, et al
    Large diversity of linezolid-resistant isolates discovered in food-producing animals through linezolid selective monitoring in Belgium in 2019.
    J Antimicrob Chemother. 2021;77:49-57.
    >> Share

  253. DE CARVALHO CCCR, Taglialegna A, Rosato AE
    Impact of PrsA on membrane lipid composition during daptomycin-resistance-mediated beta-lactam sensitization in clinical MRSA strains.
    J Antimicrob Chemother. 2021;77:135-147.
    >> Share

  254. YOON EJ, Kim HS, Woo H, Choi YJ, et al
    Trajectory of genetic alterations associated with colistin resistance in Acinetobacter baumannii during an in-hospital outbreak of infection.
    J Antimicrob Chemother. 2021;77:69-73.
    >> Share

  255. BAE M, Jeong Y, Bae S, Kim MJ, et al
    Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study.
    J Antimicrob Chemother. 2021;77:223-228.
    >> Share

  256. BUCKLEY AM, Moura IB, Altringham J, Ewin D, et al
    The use of first-generation cephalosporin antibiotics, cefalexin and cefradine, is not associated with induction of simulated Clostridioides difficile infection.
    J Antimicrob Chemother. 2021;77:148-154.
    >> Share

  257. CAMERON-MCDERMOTT SM, Barrow GJ, Webster AM, De La Haye CO, et al
    Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and syndromic treatment of men with urethral discharge in Kingston, Jamaica, 2018-19.
    J Antimicrob Chemother. 2021;77:218-222.
    >> Share

  258. WILLEMS RPJ, van Dijk K, Dierikx CM, Twisk JWR, et al
    Gastric acid suppression, lifestyle factors and intestinal carriage of ESBL and carbapenemase-producing Enterobacterales: a nationwide population-based study.
    J Antimicrob Chemother. 2021;77:237-245.
    >> Share

  259. STEMLER J, Lackner M, Chen SC, Hoenigl M, et al
    EQUAL Score Scedosporiosis/Lomentosporiosis 2021: a European Confederation of Medical Mycology (ECMM) tool to quantify guideline adherence.
    J Antimicrob Chemother. 2021;77:253-258.
    >> Share

  260. NURJADI D, Klein S, Hannesen J, Heeg K, et al
    Molecular analysis of an increase in trimethoprim/sulfamethoxazole-resistant MRSA reveals multiple introductions into a tertiary care hospital, Germany 2012-19.
    J Antimicrob Chemother. 2021;77:38-48.
    >> Share

  261. JIAN Y, Li T, Zhao L, Zhao N, et al
    Regulation of bla system in ST59-related oxacillin-susceptible mecA-positive Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Dec 16. pii: 6464066. doi: 10.1093.
    >> Share

  262. CINTHI M, Coccitto SN, Fioriti S, Morroni G, et al
    Occurrence of a plasmid co-carrying cfr(D) and poxtA2 linezolid resistance genes in Enterococcus faecalis and Enterococcus casseliflavus from porcine manure, Italy.
    J Antimicrob Chemother. 2021 Dec 15. pii: 6463073. doi: 10.1093.
    >> Share

  263. SHANG Y, Lv P, Su D, Li Y, et al
    Evolutionary conservative analysis revealed novel functional sites in the efflux pump NorA of Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Dec 15. pii: 6463078. doi: 10.1093.
    >> Share

  264. PIRES J, Huisman JS, Bonhoeffer S, Van Boeckel TP, et al
    Increase in antimicrobial resistance in Escherichia coli in food animals between 1980 and 2018 assessed using genomes from public databases.
    J Antimicrob Chemother. 2021 Dec 11. pii: 6459599. doi: 10.1093.
    >> Share

  265. HOLLAND M, Bjanes E, Nizet V, Dillon N, et al
    Bicarbonate modulates delafloxacin activity against MDR Staphylococcus aureus and Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2021 Dec 10. pii: 6459101. doi: 10.1093.
    >> Share

  266. CEBALLOS-GARZON A, Monteoliva L, Gil C, Alvarez-Moreno C, et al
    Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata.
    J Antimicrob Chemother. 2021 Dec 10. pii: 6459103. doi: 10.1093.
    >> Share

  267. DIAZ-DIAZ S, Recacha E, Garcia-Duque A, Docobo-Perez F, et al
    Effect of RecA inactivation and detoxification systems on the evolution of ciprofloxacin resistance in Escherichia coli.
    J Antimicrob Chemother. 2021 Dec 8. pii: 6456190. doi: 10.1093.
    >> Share

    November 2021
  268. CHEUNG CY, McNeil MB, Cook GM
    Utilization of CRISPR interference to investigate the contribution of genes to pathogenesis in a macrophage model of Mycobacterium tuberculosis infection.
    J Antimicrob Chemother. 2021 Nov 28. pii: 6445137. doi: 10.1093.
    >> Share

  269. COCCITTO SN, Cinthi M, Fioriti S, Morroni G, et al
    Linezolid-resistant Enterococcus gallinarum isolate of swine origin carrying cfr, optrA and poxtA genes.
    J Antimicrob Chemother. 2021 Nov 23. pii: 6433473. doi: 10.1093.
    >> Share

  270. WILCOX MH, Dryden M
    Update on the epidemiology of healthcare-acquired bacterial infections: focus on complicated skin and skin structure infections.
    J Antimicrob Chemother. 2021;76.
    >> Share

  271. MARR I, Swe K, Henderson A, Lacey JA, et al
    Cefazolin susceptibility of coagulase-negative staphylococci (CoNS) causing late-onset neonatal bacteraemia.
    J Antimicrob Chemother. 2021 Nov 13. pii: 6427455. doi: 10.1093.
    >> Share

  272. MYLONA E, Voong Vinh P, Qureshi S, Karkey A, et al
    Tebipenem as an oral alternative for the treatment of typhoid caused by XDR Salmonella Typhi.
    J Antimicrob Chemother. 2021;76:3197-3200.
    >> Share

  273. AL-MIR H, Osman M, Drapeau A, Hamze M, et al
    Spread of ESC-, carbapenem- and colistin-resistant Escherichia coli clones and plasmids within and between food workers in Lebanon.
    J Antimicrob Chemother. 2021;76:3135-3143.
    >> Share

  274. ZHANG S, Liu P, Wang Y, Shen Z, et al
    Multiresistance gene cfr(C) in Clostridium perfringens of cattle origin from China.
    J Antimicrob Chemother. 2021;76:3310-3312.
    >> Share

  275. BOOSTROM I, Bala Y, Vasic JM, Gluvakov J, et al
    Evaluation of the MYCOPLASMA IST3 urogenital mycoplasma assay in an international multicentre trial.
    J Antimicrob Chemother. 2021;76:3175-3182.
    >> Share

  276. LO FWY, Kong FYS, Hocking JS
    Treatment efficacy for rectal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials.
    J Antimicrob Chemother. 2021;76:3111-3124.
    >> Share

  277. SHASKOLSKIY B, Kandinov I, Kravtsov D, Filippova M, et al
    Prediction of ceftriaxone MIC in Neisseria gonorrhoeae using DNA microarray technology and regression analysis.
    J Antimicrob Chemother. 2021;76:3151-3158.
    >> Share

  278. HEARD F, Sehgal A
    Vancomycin in adult prescribing: is it time to move on from trough-based dosing in the UK?
    J Antimicrob Chemother. 2021;76:3071-3072.
    >> Share

  279. RAUWOLF KK, Hoertnagl C, Lass-Floerl C, Groll AH, et al
    Interaction in vitro of pulmonary surfactant with antifungal agents used for treatment and prevention of invasive aspergillosis.
    J Antimicrob Chemother. 2021 Nov 11. pii: 6425642. doi: 10.1093.
    >> Share

  280. EGAN SA, Kavanagh NL, Shore AC, Mollerup S, et al
    Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland.
    J Antimicrob Chemother. 2021 Nov 8. pii: 6423109. doi: 10.1093.
    >> Share

  281. TANG N, Hu J, Zhao Y, Song Y, et al
    In vivo evolution of carbapenem resistance in hypervirulent Klebsiella pneumoniae in a patient undergoing long-term treatment.
    J Antimicrob Chemother. 2021 Nov 2. pii: 6415960. doi: 10.1093.
    >> Share

    October 2021
  282. PRATAMA R, Beukers AG, McIver CJ, Keighley CL, et al
    A vanA vancomycin-resistant Enterococcus faecium ST80 outbreak resulting from a single importation event.
    J Antimicrob Chemother. 2021 Oct 29. pii: 6414308. doi: 10.1093.
    >> Share

  283. JEN FE, El-Deeb IM, Zalucki YM, Edwards JL, et al
    A drug candidate for Alzheimer's and Huntington's disease, PBT2, can be repurposed to render Neisseria gonorrhoeae susceptible to natural cationic antimicrobial peptides.
    J Antimicrob Chemother. 2021;76:2850-2853.
    >> Share

  284. BORTOLAIA V, Ronco T, Romascu L, Nicorescu I, et al
    Co-localization of carbapenem (blaOXA-162) and colistin (mcr-1) resistance genes on a transferable IncHI2 plasmid in Escherichia coli of chicken origin.
    J Antimicrob Chemother. 2021;76:3063-3065.
    >> Share

  285. ADACHI F, Sekizuka T, Yamato M, Fukuoka K, et al
    Characterization of FRI carbapenemase-producing Enterobacter spp. isolated from a hospital and the environment in Osaka, Japan.
    J Antimicrob Chemother. 2021;76:3061-3062.
    >> Share

  286. GOLDEN AR, Karlowsky JA, Walkty A, Baxter MR, et al
    Comparison of phenotypic antimicrobial susceptibility testing results and WGS-derived genotypic resistance profiles for a cohort of ESBL-producing Escherichia coli collected from Canadian hospitals: CANWARD 2007-18.
    J Antimicrob Chemother. 2021;76:2825-2832.
    >> Share

  287. KARLOWSKY JA, Walkty A, Golden AR, Baxter MR, et al
    ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007-18.
    J Antimicrob Chemother. 2021;76:2815-2824.
    >> Share

  288. ZAHR N, Urien S, Aubry A, Chauvin C, et al
    Ciprofloxacin population pharmacokinetics during long-term treatment of osteoarticular infections.
    J Antimicrob Chemother. 2021;76:2906-2913.
    >> Share

  289. RING K, Shiva F
    Comment on: Clinical and serological outcomes in patients treated with oral doxycycline for early neurosyphilis.
    J Antimicrob Chemother. 2021;76:3067-3068.
    >> Share

  290. ADAMSON PC, Lin EY, Ha SM, Klausner JD, et al
    Using a public database of Neisseria gonorrhoeae genomes to detect mutations associated with zoliflodacin resistance.
    J Antimicrob Chemother. 2021;76:2847-2849.
    >> Share

  291. GOLDSTEIN E
    Rise in the prevalence of resistance to extended-spectrum cephalosporins in the USA, nursing homes and antibiotic prescribing in outpatient and inpatient settings.
    J Antimicrob Chemother. 2021;76:2745-2747.
    >> Share

  292. CHARRET L, Bart G, Hoppe E, Dernis E, et al
    Clinical characteristics and management of olecranon and prepatellar septic bursitis in a multicentre study.
    J Antimicrob Chemother. 2021;76:3029-3032.
    >> Share

    September 2021
  293. ENGBERG J, Vejrum LK, Madsen TV, Nielsen XC, et al
    Verification of analytical bacterial spectrum of QIAstat-Dx(R) GI V2 and Novodiag(R) Bacterial GE+ V2-0 diagnostic panels.
    J Antimicrob Chemother. 2021;76.
    >> Share

  294. ZHANG X, Wang L, Li D, Wang C, et al
    Characterization of the novel plasmid-encoded MBL gene blaAFM-1, integrated into a blaIMP-45-bearing transposon Tn6485e in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
    J Antimicrob Chemother. 2021 Sep 17. pii: 6371932. doi: 10.1093.
    >> Share

  295. DIEZ-AGUILAR M, Ekkelenkamp M, Morosini MI, Huertas N, et al
    Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates.
    J Antimicrob Chemother. 2021;76:2578-2585.
    >> Share

  296. SASS G, Larwood DJ, Martinez M, Shrestha P, et al
    Efficacy of nikkomycin Z in murine CNS coccidioidomycosis: modelling sustained-release dosing.
    J Antimicrob Chemother. 2021;76:2629-2635.
    >> Share

  297. GEBREMARIAM T, Gu Y, Singh S, Kitt TM, et al
    Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis.
    J Antimicrob Chemother. 2021;76:2636-2639.
    >> Share

  298. DARAGON B, Fournier D, Plesiat P, Jeannot K, et al
    Performance of disc diffusion, MIC gradient tests and Vitek 2 for ceftolozane/tazobactam and ceftazidime/avibactam susceptibility testing of Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2021;76:2586-2592.
    >> Share

  299. PALACE SG, Fryling KE, Li Y, Wentworth AJ, et al
    Identification of bile acid and fatty acid species as candidate rapidly bactericidal agents for topical treatment of gonorrhoea.
    J Antimicrob Chemother. 2021;76:2569-2577.
    >> Share

  300. ROYER G, Poirel L, La Combe B, Clermont O, et al
    Lack of association between colistin resistance and chlorhexidine reduced susceptibility in clinical isolates of Escherichia coli.
    J Antimicrob Chemother. 2021;76:2736-2737.
    >> Share

  301. MAMA OM, Aspiroz C, Lozano C, Ruiz-Ripa L, et al
    Penicillin susceptibility among invasive MSSA infections: a multicentre study in 16 Spanish hospitals.
    J Antimicrob Chemother. 2021;76:2519-2527.
    >> Share

  302. RAISANEN K, Sarvikivi E, Arifulla D, Pietikainen R, et al
    Three clusters of carbapenemase-producing Citrobacter freundii in Finland, 2016-20.
    J Antimicrob Chemother. 2021;76:2697-2701.
    >> Share

  303. BIEDRZYCKA M, Urbanowicz P, Guzek A, Brisse S, et al
    Dissemination of Klebsiella pneumoniae ST147 NDM-1 in Poland, 2015-19.
    J Antimicrob Chemother. 2021;76:2538-2545.
    >> Share

  304. ABE R, Oyama F, Akeda Y, Nozaki M, et al
    Hospital-wide outbreaks of carbapenem-resistant Enterobacteriaceae horizontally spread through a clonal plasmid harbouring blaIMP-1 in children's hospitals in Japan.
    J Antimicrob Chemother. 2021 Sep 3. pii: 6363635. doi: 10.1093.
    >> Share

    August 2021
  305. MOUNSEY O, Schubert H, Findlay J, Morley K, et al
    Limited phylogenetic overlap between fluoroquinolone-resistant Escherichia coli isolated on dairy farms and those causing bacteriuria in humans living in the same geographical region.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358704. doi: 10.1093.
    >> Share

  306. URBANOWICZ P, Izdebski R, Baraniak A, Zabicka D, et al
    Molecular and genomic epidemiology of VIM/IMP-like metallo-beta-lactamase-producing Pseudomonas aeruginosa genotypes in Poland.
    J Antimicrob Chemother. 2021;76:2273-2284.
    >> Share

  307. TYDEMAN F, Craine N, Kavanagh K, Adams H, et al
    Incidence of Clostridioides difficile infection (CDI) related to antibiotic prescribing by GP surgeries in Wales.
    J Antimicrob Chemother. 2021;76:2437-2445.
    >> Share

  308. MUNTEAN MM, Muntean AA, Guerin F, Cattoir V, et al
    Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers.
    J Antimicrob Chemother. 2021;76:2294-2301.
    >> Share

  309. SIX A, Mosbahi K, Barge M, Kleanthous C, et al
    Pyocin efficacy in a murine model of Pseudomonas aeruginosa sepsis.
    J Antimicrob Chemother. 2021;76:2317-2324.
    >> Share

  310. LI R, Peng K, Xiao X, Wang Y, et al
    Characterization of novel ISAba1-bounded tet(X15)-bearing composite transposon Tn6866 in Acinetobacter variabilis.
    J Antimicrob Chemother. 2021;76:2481-2483.
    >> Share

  311. VADLAMUDI NK, Saatchi A, Patrick DM, Rose C, et al
    Impact of the 13-valent pneumococcal conjugate vaccine on acute otitis media and acute sinusitis epidemiology in British Columbia, Canada.
    J Antimicrob Chemother. 2021;76:2419-2427.
    >> Share

  312. MACVANE SH, Bhalodi AA, Dare RK, Rosenbaum ER, et al
    Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest BC Kit.
    J Antimicrob Chemother. 2021;76:2453-2463.
    >> Share

  313. COCCITTO SN, Fioriti S, Cinthi M, Morroni G, et al
    Detection of phenicol-oxazolidinone resistance gene optrA in Aerococcus viridans from bovine faeces, Italy.
    J Antimicrob Chemother. 2021;76:2479-2481.
    >> Share

    July 2021
  314. LUCENA NEMIROSKY J, Espelt R, Lopez Grado E, Sobrino J, et al
    Macrolide resistance in Mycoplasma genitalium in Catalonia, Spain: a 1 year prospective study.
    J Antimicrob Chemother. 2021 Jul 19. pii: 6323546. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016